HomeKZR • NASDAQ
add
Kezar Life Sciences Inc
Previous close
$6.25
Day range
$6.23 - $6.37
Year range
$3.53 - $7.02
Market cap
46.50M USD
Avg Volume
46.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.34M | -12.60% |
Net income | -11.23M | 44.73% |
Net profit margin | — | — |
Earnings per share | -1.53 | 44.96% |
EBITDA | -12.03M | 45.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 90.22M | -39.20% |
Total assets | 97.73M | -40.44% |
Total liabilities | 14.75M | -50.89% |
Total equity | 82.98M | — |
Shares outstanding | 7.32M | — |
Price to book | 0.55 | — |
Return on assets | -29.62% | — |
Return on capital | -31.14% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -11.23M | 44.73% |
Cash from operations | -9.83M | 43.81% |
Cash from investing | 15.71M | -34.70% |
Cash from financing | -1.30M | — |
Net change in cash | 4.57M | -30.60% |
Free cash flow | -6.12M | 54.81% |
About
Founded
2015
Headquarters
Website
Employees
55
